Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey W Schindler

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biomedicines|February 25, 2022
Gene Therapy Developments for Pompe DiseaseZeenath Unnisa, John K Yoon, Jeffrey W Schindler, et al.
Nature Biotechnology|December 9, 2008
Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cellsAdlen Foudi, Konrad Hochedlinger, Denille Van Buren, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domainJohn M Lamar, Patrick Stern, Hui Liu, et al.
Cell Stem Cell|July 3, 2009
TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemiaJeffrey W Schindler, Denille Van Buren, Adlen Foudi, et al.
Genes & Development|September 17, 2004
Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survivalHanno Hock, Eliza Meade, Sarah Medeiros, et al.
Nature|October 1, 2004
Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cellsHanno Hock, Melanie J Hamblen, Heather M Rooke, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseYildirim Dogan, Cecilia N Barese, Jeffrey W Schindler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2022
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosingRobert N Plasschaert, Mark P DeAndrade, Fritz Hull, et al.
Nature Cell Biology|October 30, 2019
Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivoJustin Brumbaugh, Ik Soo Kim, Fei Ji, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2024
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K Yoon, Jeffrey W Schindler, Mariana Loperfido, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biomedicines|February 25, 2022
Gene Therapy Developments for Pompe DiseaseZeenath Unnisa, John K Yoon, Jeffrey W Schindler, et al.
Nature Biotechnology|December 9, 2008
Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cellsAdlen Foudi, Konrad Hochedlinger, Denille Van Buren, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domainJohn M Lamar, Patrick Stern, Hui Liu, et al.
Cell Stem Cell|July 3, 2009
TEL-AML1 corrupts hematopoietic stem cells to persist in the bone marrow and initiate leukemiaJeffrey W Schindler, Denille Van Buren, Adlen Foudi, et al.
Genes & Development|September 17, 2004
Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survivalHanno Hock, Eliza Meade, Sarah Medeiros, et al.
Nature|October 1, 2004
Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cellsHanno Hock, Melanie J Hamblen, Heather M Rooke, et al.
Molecular Therapy. Methods & Clinical Development|November 24, 2022
Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe diseaseYildirim Dogan, Cecilia N Barese, Jeffrey W Schindler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 26, 2022
High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosingRobert N Plasschaert, Mark P DeAndrade, Fritz Hull, et al.
Nature Cell Biology|October 30, 2019
Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivoJustin Brumbaugh, Ik Soo Kim, Fei Ji, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 19, 2024
Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestationsJohn K Yoon, Jeffrey W Schindler, Mariana Loperfido, et al.
Pageof 1